Literature DB >> 2930814

Nocturnal plasma melatonin levels in schizophrenic patients.

F Fanget1, B Claustrat, J Dalery, J Brun, J L Terra, M Marie-Cardine, J Guyotat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2930814     DOI： 10.1016/0006-3223(89)90205-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  9 in total

1.  Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia.

Authors:  Cigdem Sahbaz; Omer Faruk Özer; Ayse Kurtulmus; Ismet Kırpınar; Fikrettin Sahin; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2019-02-13       Impact factor: 3.584

2.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 3.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

4.  Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial.

Authors:  Yukihiko Shirayama; Michio Takahashi; Masatoshi Suzuki; Yoshiaki Tsuruoka; Koichi Sato
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

5.  Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study.

Authors:  Rituparna Maiti; Biswa Ranjan Mishra; Monalisa Jena; Archana Mishra; Santanu Nath
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-02-28       Impact factor: 2.582

Review 6.  Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.

Authors:  Sébastien Lalanne; Claire Fougerou-Leurent; George M Anderson; Carmen M Schroder; Tali Nir; Sylvie Chokron; Richard Delorme; Bruno Claustrat; Eric Bellissant; Solenn Kermarrec; Patricia Franco; Laure Denis; Sylvie Tordjman
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

Review 7.  Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.

Authors:  Lindsay M Melhuish Beaupre; Gregory M Brown; Vanessa F Gonçalves; James L Kennedy
Journal:  Transl Psychiatry       Date:  2021-06-02       Impact factor: 6.222

Review 8.  Role of melatonin in schizophrenia.

Authors:  Armando L Morera-Fumero; Pedro Abreu-Gonzalez
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

Review 9.  Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review.

Authors:  Megan Anne Arroll; Lorraine Wilder; James Neil
Journal:  Nutr J       Date:  2014-09-16       Impact factor: 3.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.